Cytospire Therapeutics Limited
- Company number
- 14688240
- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 24 Feb 2023
- Nature of business
- Research and experimental development on biotechnology
- Corporate group
- Abingworth Ccd Gp Limited (14 companies)
Registered office
Officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| SMITH, Owen Philip | Director | 22 Nov 2023 |
Control
| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Abingworth Bioventures 8 Gp Lp | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent |
28 Apr 2023 | |
| 4bio Ventures Iii Gp Llp | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent |
30 Nov 2023 | 3 Oct 2024 |
| Mark Uden | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent |
24 Feb 2023 | 30 Nov 2023 |
| Natalie Marianne Mount | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent |
24 Feb 2023 | 30 Nov 2023 |
Accounts
| Year ended |
|---|
| 31 Mar 2026 |
| 31 Mar 2025 |
| 31 Mar 2024 |
Connections
Owned by
Cytospire Therapeutics Limited → Abingworth Bioventures 8 Gp LP → Abingworth General Partner 8 LLP → Abingworth Bioventures Gp Limited
Directors’ other companies
- SMITH, Owen Philip - Director at Entact Bio Limited
- SMITH, Owen Philip - Director at Vianautis Bio Limited
- SMITH, Owen Philip - Director at Oyster Therapeutics Ltd
Registered address
1,509 companies are registered at this address - likely a registration agent.